Cagrilintide is an investigational long-acting amylin receptor agonist and amylin analog for research use only. It is designed to mimic the pancreatic hormone amylin by activating calcitonin/amylin receptors in the area postrema and hypothalamus. This research-grade lyophilized powder is synthesized under strict quality controls and provided with full analytical documentation.
Key Scientific Attributes
- High-purity Cagrilintide (≥98% by HPLC/MS, acetate salt form)
- Verified 37-amino-acid sequence with C14 fatty acid lipidation at Lys²
- Lyophilized formulation for maximum long-term stability
- Full Certificate of Analysis (COA) with HPLC, MS, lipidation verification, and receptor-binding data
- Manufactured in GMP-aligned, ISO-compliant facilities
- Suitable for amylin receptor and energy homeostasis research
Research-Referenced Attributes (Based on published preclinical literature; not therapeutic claims.)
- Extended half-life profile compared to native amylin, supporting sustained receptor engagement in laboratory models
- Demonstrated amylin/calcitonin receptor binding affinity (AMYR) suitable for in vitro receptor studies
- Structural characterization consistent with NNC0174-0833 reference sequence, including correct C14 lipidation
- Relevant to in vitro studies examining gastric motility signaling, satiety pathway modeling, and incretin receptor crosstalk
Why Researchers Choose Our Cagrilintide
- Exact reference-sequence match with correct C14 lipidation for structural fidelity in laboratory assays
- Transparent analytical data (HPLC >98%, MS confirmation of lipidated structure)
- Competitive research pricing with bulk options
For Research Use Only. Not for human use.
